James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Amazon Is Making Twilio Inc (TWLO) Stock Tough to Own

If you thought Twilio's (TWLO) 60% pullback since September was painful, GER's Trip Chowdhry thinks TWLO stock will get worse.

Why Nvidia Corporation (NVDA), L Brands Inc (LB) and Kate Spade & Co (KATE) Are 3 of Today’s Worst Stocks

Nvidia (NVDA), L Brands (LB) and Kate Spade (KATE) collectively used more than their fair share of red ink on Tuesday.

Why General Motors Company (GM) Stock Is the Best of Its Breed

GM stock may not be easy to own right now, but when the automobile industry is firing on all cylinders, General Motors is a beast.

Why General Motors Company (GM), Acorda Therapeutics Inc (ACOR) and United Therapeutics Corporation (UTHR) Are 3 of Today’s Worst Stocks

Acorda Therapeutics (ACOR), General Motors (GM) and United Therapeutics (UTHR) investors ended up wishing last weekend was a three-day weekend.

The 5 Best Stocks to Buy for April

Several tech blue-chips are among the best stocks to buy for the upcoming month. Here's a look at five winning picks for April.